C25 Chemically-Induced Disorders .
C25.775 Substance-Related Disorders .
C25.775.675 Opioid-Related Disorders .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.400 Neuropeptides .
D12.644.400.575 Opioid Peptides .
D12.776 Proteins .
D12.776.543 Membrane Proteins .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.695 Receptors, G-Protein-Coupled .
D12.776.543.750.695.620 Receptors, Opioid .
D12.776.543.750.720 Receptors, Neurotransmitter .
D12.776.543.750.720.600 Receptors, Neuropeptide .
D12.776.543.750.720.600.610 Receptors, Opioid .
D12.776.543.750.750 Receptors, Peptide .
D12.776.543.750.750.555 Receptors, Neuropeptide .
D12.776.543.750.750.555.610 Receptors, Opioid .
D12.776.631 Nerve Tissue Proteins .
D12.776.631.650 Neuropeptides .
D12.776.631.650.575 Opioid Peptides .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.277 Central Nervous System Depressants .
D27.505.696.277.600 Narcotics .
D27.505.696.277.600.500 Analgesics, Opioid .
D27.505.696.663 Peripheral Nervous System Agents .
D27.505.696.663.850 Sensory System Agents .
D27.505.696.663.850.014 Analgesics .
D27.505.696.663.850.014.760 Narcotics .
D27.505.696.663.850.014.760.500 Analgesics, Opioid .
D27.505.954 Therapeutic Uses .
D27.505.954.427 Central Nervous System Agents .
D27.505.954.427.040 Analgesics .
D27.505.954.427.040.550 Narcotics .
D27.505.954.427.040.550.500 Analgesics, Opioid .
D27.505.954.427.210 Central Nervous System Depressants .
D27.505.954.427.210.600 Narcotics .
D27.505.954.427.210.600.500 Analgesics, Opioid .
F03 Mental Disorders .
F03.900 Substance-Related Disorders .
F03.900.675 Opioid-Related Disorders .
Terms Synonyms & Historicals Documents LILACS e MDL
Analgesics, Opioid . Full Opioid Agonists . Opioid Full Agonists . Opioid Mixed Agonist-Antagonists . Opioid Partial Agonists . Partial Opioid Agonists . Agonist-Antagonists, Opioid Mixed . Agonists, Full Opioid . Agonists, Opioid Full . Agonists, Opioid Partial . Agonists, Partial Opioid . Full Agonists, Opioid . Mixed Agonist-Antagonists, Opioid . Opioid Agonists, Full . Opioid Agonists, Partial . Opioid Mixed Agonist Antagonists . Partial Agonists, Opioid . Opioid Analgesics . Opioids . Analgesics, Addictive . Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. . 1.00
Receptors, Opioid . Endorphin Receptor . Enkephalin Receptor . Normorphine Receptors . Opiate Receptor . Opiate Receptors . Opioid Receptor . Receptors, Normorphine . Receptors, beta-Endorphin . beta-Endorphin Receptor . Receptor, Endorphin . Receptor, Enkephalin . Receptor, Opiate . Receptor, Opioid . Receptor, beta-Endorphin . Receptors, beta Endorphin . beta Endorphin Receptor . beta-Endorphin Receptors . Endorphin Receptors . Enkephalin Receptors . Narcotic Receptors . Opioid Receptors . Receptors, Enkephalin . Receptors, Narcotic . Receptors, Opiate . Receptors, Endorphin . Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. . 0.70
Opioid Peptides . Endogenous Opiates . Opiate Peptides . Opioid Peptide . Peptide, Opioid . Peptides, Opiate . Peptides, Opioid . Opiates, Endogenous . The endogenous peptides with opiate-like activity. The three major classes currently recognized are the ENKEPHALINS, the DYNORPHINS, and the ENDORPHINS. Each of these families derives from different precursors, proenkephalin, prodynorphin, and PRO-OPIOMELANOCORTIN, respectively. There are also at least three classes of OPIOID RECEPTORS, but the peptide families do not map to the receptors in a simple way. . 0.68